Merck Announces Neoclease as Winner of 2025 North American Advance Biotech Grant

Contributed by: Business Wire

Logo

Images

Neoclease receives Merck’s North American Advance Biotech Grant.

Business Wire embedded0

Tags

Research

Technology

Genetics

Health Technology

Professional Services

Start-Up

Biotechnology

Health

Science

Artificial Intelligence

Merck

More Like This

Kenai Therapeutics Announces $82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases

Merz Enters Asset Purchase Agreement With a US-Based Biotech Company

Amplo Biotechnology Announces Three Presentations at the European Society of Gene and Cell Therapy 31st Annual Congress

Merck scientist working in company's Burlington, MA, USA cell culture facility (Photo: Business Wire)

Merck Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio

Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases

Merck Collaborates with Acceleration Consortium on Open-Sourcing AI-Driven Experimentation Planner

Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration

BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development